| PERIOD ENDING | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | 31-Jul-08 | | Total Revenue | 1,434,408 | 790,976 | 481,379 | 478,154 | | Cost of Revenue | 173,072 | 178,160 | 160,321 | 153,203 | | | Gross Profit | 1,261,336 | 612,816 | 321,058 | 324,951 | | | Operating Expenses | | Research Development | 132,866 | 143,249 | 136,217 | 156,730 | | Selling General and Administrative | 353,944 | 347,462 | 251,283 | 262,386 | | Non Recurring | 10,464 | 12,548 | 9,588 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 764,062 | 109,557 | (76,030) | (94,165) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,484 | 6,190 | (1,291) | 14,270 | | Earnings Before Interest And Taxes | 770,546 | 115,747 | (77,321) | (79,895) | | Interest Expense | 12,642 | 11,686 | 11,731 | 11,901 | | Income Before Tax | 757,904 | 104,061 | (89,052) | (91,796) | | Income Tax Expense | 272,868 | 18,650 | (37,117) | (30,260) | | Minority Interest | (216) | (371) | (209) | (324) | | | | Net Income From Continuing Ops | 484,820 | 85,040 | (52,144) | (61,860) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 484,820 | 85,040 | (52,144) | (61,860) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $484,820 | $85,040 | ($52,144) | ($61,860) |
|
0.45% Nasdaq 
0.20%
Income Statement
